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Dr Jon Matsumura (Chicago, Ill). Thirty-eight percent of
the patients in the fem-pop group had Rutherford class 4 to 6 vs
18% in the endo group. Did you look at results stratified by CLI or
do you have a multivariate analysis? Patency results may be influ-
enced by the fem-pop group being enriched with patients with
more severe ischemia.
If you did PTA and it looked beautiful, why did you still place
a stent-graft? Did you consider having an arm with PTA and
selective application of the device?
Dr John C. Kedora.We did not consider doing simply a PTA
arm. We went into this study design with the thought that we
would primarily treat patients with the stent graft, regardless of
whether or not their PTA result was adequate. Our experience has
shown this to give better long-term patency. As far as dividing into
a subset of chronic limb ischemia categories, we did not stratify the
data by that method.
Dr Enrico Ascher (Brooklyn, NY). Did you balloon angio-
plasty the lesion before placing the stent or did you place the stent
graft and then balloon it?
Dr Kedora. All lesions were predilated by angioplasty and
then the stent graft was placed. The stent graft was then modeled
with angioplasty post deployment as well.
Dr Ascher. And how many of these were above the knee and
how many were below the knee?
Dr Kedora. All these were placed above the knee.
Dr Takao Ohki (Bronx, NY). I wasn’t quite sure about your
inclusion criteria. But if I may recall, you said that the patient wasbe appropriate based on an attending’s opinion. After all, you had
a number of TASC Type A lesions, as well as B, C and D.
In the TASC document it does say clearly that TASC A is
better treated with interventional treatment, whereas TASC D is
best treated with bypass. The real question is what to do with
TASC B and C. You should have randomized these patients, then
it would have been a much more valuable study.
Dr Kedora. I think you are right that the evidence for TASC
A lesions is that they are definitely better treated with endovascular
means. I also believe, at least in our study, we wanted to do a true
randomized, prospective study. All patients were well informed of
the chance that if they had a less significant lesion that there was the
chance that they would undergo a surgical bypass and, fortunately,
we had patients that agreed to both.
Dr Kenneth Ouriel (Cleveland, Ohio). Sometimes when you
do a study, you become an expert in a technique and you employ
that technique in patients outside of the scope of the study. And so
I have a somewhat politically charged question for you. What do
you think about using these devices for popliteal aneurysms with
the distal portion of the stent graft below the level of the knee
joint?
Dr Kedora. Evaluation for treatment of popliteal aneurysms
with this graft have yet to be done. In most cases, in our treatment
group, there was disease in the proximal portion of the popliteal
artery, and we were comfortable with placing the stent graft, at
least in the proximal portion.
DrOuriel.Did you use these at all in patients that needed the
distal to be below the level of the knee joint?Dr Kedora. No, sir, we did not.
